Samuel W. Fordyce Professor Department of Neurology and Psychiatry St Louis Univ. School of Medicine
Psychiatry
Dr. George T. Grossberg, MD
|
|
Give Review
George T. Grossberg, MD practices Psychiatry. He graduated from Saint Louis University School of Medicine. Saint Louis University School of Medicine is ranked 67/57 in Research/PrimaryCare. He received awards:"America's Top Doctors", "St. Louis Magazine: Top Doctors", "Whos Who in Medicine and Healthcare" and "Top MD". George Grossberg has written publications. He has 100 publications published with PubMed. The lastest paper is: 'The role of the psychiatrist in Alzheimer's disease.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Quality Improvement in Skilled Nursing Facilities for Residents With Alzheimer's Disease.
- Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.
- Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication.
- Evaluating High-Dose Rivastigmine Patch in Severe Alzheimer's Disease: Analyses with Concomitant Memantine Usage as a Factor.
- A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzhei...
- Transdermal rivastigmine in the treatment of Alzheimer's disease: current and future directions.
- A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine.
- Impact of exogenous testosterone on Mood: A systematic review and meta-analysis of randomized placebo-controlled trials.
- Efficacy of higher-dose 13.3 mg/24 h (15 cm(2) ) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis.
- Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on InstruMental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease.
- A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia.
- Caregiver health: health of caregivers of Alzheimer's and other dementia patients.
- Prevalence of Parkinson Disease and Parkinson Disease Dementia in Community Nursing Homes.
- Phantom limb pain: mechanisms and treatment approaches.
- Predictors of sustained response to rivastigmine in patients with Alzheimer's disease: a retrospective analysis.
- Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
- Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.
- Geriatric psychiatry--an emerging specialty.
- Healthy brain aging: a road map.
- Dementia risk prediction: are we there yet?
- The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: recommendations of an expert consensus panel.
- Buspirone in Alzheimer's disease.
- Atypical antipsychotics and the risk of diabetes in an elderly population in long-term care: a retrospective nursing home chart review study.
- Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.
- Mood Disorders in the elderly.
- Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
- Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
- An open-label trial of adjunctive oxcarbazepine for bipolar Disorder.
- Rationalizing therapeutic approaches in Alzheimer's disease.
- Alzheimer's disease pathways to practice: assessing diagnosis and outcome measures.
- Unmet visual needs of Alzheimer''s disease patients in long-term care facilities.
- Diagnosis and treatment of Alzheimer's disease.
- Academic highlights: emerging therapeutic strategies in Alzheimer's disease.
- Electroconvulsive therapy in the elderly.
- Geriatric Mental health. Preface.
- Herbals and botanicals in geriatric psychiatry.
- Predicting suicidal risk in schizophrenic and Schizoaffective patients in a prospective two-year trial.
- The InterSePT scale for Suicidal thinking reliability and validity.
- Management of Alzheimer's disease.
- Clozapine treatment for suicidality in Schizophrenia: International Suicide Prevention Trial (InterSePT).
- Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease.
- The ABC of Alzheimer's disease: behavioral symptoms and their treatment.
- Recognition and Management of Behavioral Disturbances in Dementia.
- Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses.
- Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.
- Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's disease.
- Trial designs likely to meet valid long-term Alzheimer''s disease progression effects: learning from the past, preparing for the future.
- The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer''s disease.
- Circadian rhythm disturbances in patients with Alzheimer''s disease: a review.
- Memantine: a review of studies into its safety and efficacy in treating Alzheimer''s disease and other dementias.
- Electroconvulsive therapy in the presence of a metallic skull plate after meningioma resection.
- Management of behavioral problems in Alzheimer''s disease.
- Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer''s disease.
- Proposed diagnostic criteria for apathy in Alzheimer''s disease and other neuropsychiatric Disorders.
- Novel regimens and delivery systems in the pharmacological treatment of Alzheimer''s disease.
- Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension.
- Management of agitation and aggression associated with Alzheimer disease.
- Impact of rivastigmine on caregiver burden associated with Alzheimer''s disease in both informal care and nursing home settings.
- Personal perspectives of persons with Alzheimer's disease and their carers: a global survey.
- Comparative study of donepezil and rivastigmine.
- A six-month double-blind, randomized, placebo-Controlled study of a transdermal patch in Alzheimer''s disease--rivastigmine patch versus capsule.
- IDEAL: a 6-month, double-blind, placebo-Controlled study of the first skin patch for Alzheimer disease.
- Memantine treatment in patients with mild to moderate Alzheimer''s disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-Controlled...
- Rivastigmine for Alzheimer''s disease.
- Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer''s disease.
- Rivastigmine in Alzheimer disease: efficacy over two years.
- Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment.
- Strategies for continued successful treatment of Alzheimer''s disease: switching cholinesterase inhibitors.
- Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized Controlled trial.
- The aging hip. St. Louis University Geriatric Grand Rounds.
- Faculty resources for teaching geriatric medicine.
- Safety and efficacy of caffeine-augmented ECT in elderly Depressives: a retrospective study.
- Drug-induced seizures in the elderly. Causative agents and optimal management.
- The natural history of Alzheimer's disease: a brain bank study.
- The older patient with psychotic symptoms.
- The use of psychotropic medication in the management of problem behaviors in the patient with Alzheimer's disease.
- Drinking behavior and vasopressin responses to hyperosmolality in Alzheimer's disease.
- Occurrence of cancer in Alzheimer and elderly Control patients: an epidemiologic necropsy study.
- Treating the agitated Alzheimer patient.
- Survey of North American and European dementia brain banks: a 1994 directory.
- The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study.
- Disinhibition, apathy, indifference, fatigability, complaining, and negativism.
- Delirium in a 75-year-old woman receiving ECT and levodopa.
- Diagnosis and treatment of psychotic symptoms in elderly patients.
- The treatment of Psychosis in late life.
- Epidemiology of psychotherapeutic Drug use in older adults.
- Estrogen as a psychotherapeutic agent.
- Issues involved in assessing competency.
- Advance directives, competency evaluation, and surrogate management in elderly patients.
- Late-life onset of psychotic symptoms.
- The role of the psychiatrist in Alzheimer's disease.
- Lack of adverse pharmacodynamic Drug interactions with rivastigmine and twenty-two classes of medications.
- Generalized anxiety Disorder in the elderly.
- A preliminary comparison of healthy elderly and young adults on the SUNYA Revision of the Psychosomatic Symptom Checklist.
- Psychiatric problems in the nursing home. St. Louis University Geriatric Grand Rounds.
- Smoking as a risk factor for Alzheimer's disease.
- Vasopressin response to dehydration in Alzheimer's disease.
- Mania induced by fluoxetine.
- Treatment of depression in the elderly.
Schools
Saint Louis University School of Medicine
D P Wohl Mem Mntl Health Institute
St Johns Mercy Med Center
St Louis University Hospital
Procedures Preformed
- Electroconvulsive Therapy (ECT)
- Psychiatric Evaluation
- Psychiatric Medication Therapy
Conditions Treated
- Adjustment Disorder
- Alcohol-Induced Mental Disorders
- Alcoholism (Alcohol Dependence)
- Anxiety
- View All
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- St. Louis Magazine: Top Doctors
- Whos Who in Medicine and Healthcare
- Top MD
Education
-
St Louis University School of Medicine -
Saint Louis University School of Medicine
Drug Facts
| NPI NUMBER | 1033135991 | |
| NPPES Provider LastName | GROSSBERG | |
| NPPES Provider FirstName | GEORGE | |
| NPPES Provider ZIPCode | 631041027 | |
| NPPES Provider State | MO | |
| Specialty Description | Geriatric Psychiatry | |
| Total Claim Count | 2498.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1033135991 |
| Last Name Of The Provider | GROSSBERG |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
|
Dr. Jeffrey Pevnick, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah Hartz, MD |
|
|
Dr. Jo-Ellyn M. Ryall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brianne M. Disabato, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nuri B. Farber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhilash K. Desai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yvette I. Sheline, MD |
|
|
Dr. Becky A. Pew, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shannon M. Jennings, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julio M. Bernardi, MD |
|
|
Dr. William A. Kelly, MD |
|
|
Dr. Naazia Azhar, MD |
|
|
Dr. Surendra Chaganti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander E. Graypel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shankar Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela C. Shay, DO |
|
|
Dr. John D. Rogakos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandeep K. Shrestha, MD
This Doctor is OpenDoctor Recommended.
|